NYSE:ABTMedical Equipment
Abbott Laboratories (NYSE:ABT) Unveils Breakthrough Leadless Pacemaker Advances In New Clinical Trials
Abbott Laboratories (NYSE:ABT) recently announced promising results from its AVEIR Conduction System Pacing study, showcasing its innovative leadless pacemaker technology. Over the last quarter, the company's stock price movement was relatively flat, rising by 1.15%. This modest gain aligns with broader market trends, where major indexes like the Dow had a slight decline and tech stocks saw some losses. Abbott's positive product announcements, alongside stable earnings and continued dividend...